- Home
- FLX vs ORGO Comparison
FLX vs ORGO Comparison
Compare FLX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLX
- ORGO
- Stock Information
- Founded
- FLX 2013
- ORGO 1985
- Country
- FLX China
- ORGO United States
- Employees
- FLX N/A
- ORGO N/A
- Industry
- FLX
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- FLX
- ORGO Health Care
- Exchange
- FLX NYSE
- ORGO Nasdaq
- Market Cap
- FLX 623.6M
- ORGO 667.1M
- IPO Year
- FLX 2024
- ORGO N/A
- Fundamental
- Price
- FLX $8.25
- ORGO $5.25
- Analyst Decision
- FLX
- ORGO Buy
- Analyst Count
- FLX 0
- ORGO 2
- Target Price
- FLX N/A
- ORGO $5.50
- AVG Volume (30 Days)
- FLX 8.5K
- ORGO 4.0M
- Earning Date
- FLX 03-12-2025
- ORGO 05-08-2025
- Dividend Yield
- FLX N/A
- ORGO N/A
- EPS Growth
- FLX N/A
- ORGO N/A
- EPS
- FLX N/A
- ORGO N/A
- Revenue
- FLX $612,152,319.00
- ORGO $482,043,000.00
- Revenue This Year
- FLX N/A
- ORGO N/A
- Revenue Next Year
- FLX N/A
- ORGO $7.62
- P/E Ratio
- FLX N/A
- ORGO N/A
- Revenue Growth
- FLX N/A
- ORGO 11.29
- 52 Week Low
- FLX $6.50
- ORGO $2.17
- 52 Week High
- FLX $21.95
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- FLX N/A
- ORGO 59.88
- Support Level
- FLX N/A
- ORGO $5.01
- Resistance Level
- FLX N/A
- ORGO $5.40
- Average True Range (ATR)
- FLX 0.00
- ORGO 0.56
- MACD
- FLX 0.00
- ORGO 0.07
- Stochastic Oscillator
- FLX 0.00
- ORGO 59.89
About FLX BINGEX LIMITED SPON ADS EACH REPR 3 CL A ORD SHS
BingEx Ltd provides on-demand dedicated courier services for individual and business customers with superior time certainty, delivery safety and service quality. The company brands its services as FlashEx, which means delivery in a flash. The Group's principal operations and geographic markets are in the People's Republic of China (PRC).
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.